OCT 02, 2020 7:00 PM PDT

Stop the Clot: A New Antibody Treatment for Thrombosis

WRITTEN BY: Tara Fernandez

Blood clotting helps stem the bleeding from a wound, suppressing blood loss and stopping pathogenic microorganisms from entering the body. However, there’s a dark side to blood clotting. A blood clot, or thrombus, that ends up in the circulation can cause a heart attack or a stroke.

Australian researchers have designed an antibody-based treatment that blocks thrombosis without the unwanted side effects of current treatments such as blood thinners and anticoagulants. This antibody, the first of its kind, targets a specific protein in the blood called Von Willebrand Factor, or VWF. The study was published in Haematologica.

Therapies to inhibit blood clotting often lead to excessive bleeding because they are not selective for “bad” blood clots, but instead stop all coagulation in the body. Moreover, they are not effective for all patients. Statistics show that four out of five patients receiving traditional antithrombotic medications continue to have cardiovascular events even during treatment.

Erik Westein from the Australian Centre for Blood Diseases at Monash University explained: “Our approach was to first identify the biological differences between normal blood clotting and pathological blood clotting, and we found that VWF changes its properties when dangerous blood clots are forming.”

"Next, we engineered an antibody that only detects and blocks this pathological form of VWF and is therefore only active when a blood clot becomes pathological.”

The team’s engineered antibody was designed to not interfere with normal blood clotting and as a result, can be administered at much higher doses compared to existing treatments.


Sources: Haematologica, Monash University.

About the Author
  • Tara Fernandez has a PhD in Cell Biology and has spent over a decade uncovering the molecular basis of diseases ranging from skin cancer to obesity and diabetes. She currently works on developing and marketing disruptive new technologies in the biotechnology industry. Her areas of interest include innovation in molecular diagnostics, cell therapies, and immunology. She actively participates in various science communication and public engagement initiatives to promote STEM in the community.
You May Also Like
JUN 07, 2021
Health & Medicine
Higher Incidence of Breast Cancer in Polluted Urban Areas
JUN 07, 2021
Higher Incidence of Breast Cancer in Polluted Urban Areas
A Taiwanese study looked at the incidence of breast cancer in areas of Taiwan with varying levels of air pollutants. Air ...
JUL 15, 2021
Immunology
Your Immune System Can't Deal With All the Plastic You're Eating
JUL 15, 2021
Your Immune System Can't Deal With All the Plastic You're Eating
Microplastics—tiny fragments of plastic, less than five millimeters in diameter—pollute our environment and, ...
JUL 19, 2021
Health & Medicine
The Pandemic and Fewer Asthma Attacks?
JUL 19, 2021
The Pandemic and Fewer Asthma Attacks?
Asthma sufferers: Quarantine during the pandemic may have not only helped you avoid COVID but more asthma attacks as wel ...
AUG 12, 2021
Immunology
Anticoagulants Target a Weak Spot in Coronavirus Variants
AUG 12, 2021
Anticoagulants Target a Weak Spot in Coronavirus Variants
Australian researchers have found a new molecular binding site on the coronavirus that causes COVID-19, a discovery that ...
AUG 31, 2021
Clinical & Molecular DX
Five Questions to Help You Select the Best Cellular Stain
AUG 31, 2021
Five Questions to Help You Select the Best Cellular Stain
Cellular stains are organic fluorescent dyes or fluorescent conjugates designed to localize to a specific organelle or c ...
AUG 20, 2021
Drug Discovery & Development
One Vaccine to Rule Them All: Researchers One Step Closer to Universal Vaccine
AUG 20, 2021
One Vaccine to Rule Them All: Researchers One Step Closer to Universal Vaccine
Researchers have identified two antibodies that can protect animals from diseases caused by alphaviruses, which are RNA ...
Loading Comments...